Last reviewed · How we verify

NCT04042584: OPTIC-AVC

Visio-conference for Pre-hospital Triage of Stroke Suspicions

Completed NA Last updated 31 March 2022
What this trial tests

NA trial testing Visio conference device evaluation (DVCM) in Stroke in 215 participants. Completed in 9 December 2021.

Timeline
20 November 2019
Primary endpoint
9 December 2021
9 December 2021

Quick facts

Lead sponsorUniversity Hospital, Bordeaux
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment215
Start date20 November 2019
Primary completion9 December 2021
Estimated completion9 December 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, any sex, with Stroke or Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Interventionnal Study to investigate the accuracy of our clinical based algorithm performed by using a visioconference device to assess the eligibility of acute recanalisation treatment (intraveinous thrombolysis (IVT) and/or mechanical thrombectomie (TM). Clinical identification of type of treatment is needed is pre-hospital triage of these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04042584.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing